Question 1

How many shares of ACRS does JACOBS LEVY EQUITY MANAGEMENT, INC own?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of ACRS (ACLARIS THERAPEUTICS INC) before exiting the position in 2025-Q2.

Question 2

What is JACOBS LEVY EQUITY MANAGEMENT, INC's ACRS position worth?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC's ACRS position was last reported at $0 in 2025-Q2 before the exit.

Question 3

Is JACOBS LEVY EQUITY MANAGEMENT, INC buying or selling ACRS?

Accepted Answer

In 2025-Q2, JACOBS LEVY EQUITY MANAGEMENT, INC exited their ACRS position entirely (-100.0% change in shares).

Question 4

When did JACOBS LEVY EQUITY MANAGEMENT, INC first buy ACRS?

Accepted Answer

Based on available 13F filings, JACOBS LEVY EQUITY MANAGEMENT, INC first reported a position in ACRS in 2024-Q3. They have held the position across 11 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$1.47	0
2025-Q1	Decreased	460,842	-20.0%	$705,088	0.0%	$1.59	0
2024-Q4	Decreased	576,042	-37.1%	$1.4M	0.0%	$2.48	0
2024-Q3	New	915,509	—	$1.1M	0.0%	$1.17	35